Monthly weight loss drug helps people lose 20% of body weight, trial finds

Monthly weight loss drug helps people lose 20% of body weight, trial finds

A monthly weight loss drug from Amgen helped people lose about 20% of their body weight,…

Continue Reading
Digital education and exercise therapy versus minimal intervention for young people at high risk of early onset knee osteoarthritis after ACL reconstruction: a study protocol for the Stop OsteoARthritis (SOAR) randomized controlled trial | Trials

Digital education and exercise therapy versus minimal intervention for young people at high risk of early onset knee osteoarthritis after ACL reconstruction: a study protocol for the Stop OsteoARthritis (SOAR) randomized controlled trial | Trials

Yu D, Jordan KP, Bedson J, Englund M, Blyth F, Turkiewicz A, et al. Population trends…

Continue Reading
Weight-loss drugs in head-to-head trial

Weight-loss drugs in head-to-head trial

Getty Images The first head-to-head trial of two blockbuster weight-loss drugs has shown Mounjaro is more…

Continue Reading
In new trial, Zepbound bests Wegovy for weight loss

In new trial, Zepbound bests Wegovy for weight loss

Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has outperformed its main competitor,…

Continue Reading
Zepbound results in more weight loss than Wegovy in trial, Eli Lilly says

Zepbound results in more weight loss than Wegovy in trial, Eli Lilly says

People who took Zepbound, Eli Lilly’s weight loss drug, shed more pounds than those on Novo…

Continue Reading
A randomized clinical trial testing digital mindset intervention for knee osteoarthritis pain and activity improvement

A randomized clinical trial testing digital mindset intervention for knee osteoarthritis pain and activity improvement

We designed this three-arm, parallel groups, randomized controlled trial (prospectively registered on ClinicalTrials.gov on 2023-01-26, NCT05698368)…

Continue Reading